Huge impact of COVID-19 outbreak on patients with diseases that can normally be treated - PACE-CME

Huge impact of COVID outbreak on patients with diseases that can normally be treated

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI
No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI
ESC 2020
No difference in outcomes after 5 years with anti-ischemic metabolic agent in patients after PCI
- Prof. Freek Verheugt, MD
Updates in the 2020 AF guidelines
Updates in the 2020 AF guidelines
ESC 2020
Updates in the 2020 AF guidelines
- Isabelle van Gelder, MD, PhD
BP lowering should be considered irrespective of prior CVD or baseline SBP
BP lowering should be considered irrespective of prior CVD or baseline SBP
ESC 2020
BP lowering should be considered irrespective of prior CVD or baseline SBP
- Kazem Rahimi, MD
Colchicine reduces primary outcome in chronic coronary disease
Colchicine reduces primary outcome in chronic coronary disease
ESC 2020
Colchicine reduces primary outcome in chronic coronary disease
- Mark Nidorf, MD